The secretin-pancreozymin (SP) and Lundh-Borgstrom (meal) tests were compared in diagnosing chronic pancreatitis (CP). A range of normal values for each test was obtained in a control group of 22 patients without pancreatic disease. Seventeen patients with CP were given the tests on separate days. The peak concentration of bicarbonate after secretin was reduced in 14 of these 17 patients, post-secretin bicarbonate output fell in 13, while peak tryptic activity (PTA) in duodenal juice after pancreozymin was below normal in 10; the overall incidence of abnormal results in SP tests was 88%. The mean tryptic activity (MTA) in a two-hour collection of duodenal juice after the test meal was reduced below normal in 16 of the 17 patients.
Introduction
Secretin-pancreozymin' and Lundh-Borgstr6m2 tests are commonly used to evaluate pancreatic function, yet there is little information on their relative usefulness in diagnosing pancreatic disease. A comparative assessment of these tests has been in progress since June 1975 in a centre with special interest in pancreatic disease. We report the results in chronic pancreatitis (CP).
Patients and methods
Of the 39 patients investigated, 22 served as controls and 17 were patients with CP. The control group comprised three volunteers and 19 patients in whom from all available information, including laparotomy in 12, the pancreas was considered to be normal. In the 17 patients with CP the diagnosis was established from characteristic histological changes in surgically resected specimens (two patients), radiological detection of pancreatic calculi (eight), or the triad of diabetes, steatorrhoea, and relapses of pancreatitis (four). In addition three young patients with documented relapses of pancreatitis starting in their 20s showed impaired glucose tolerance, and in each case the typical morphological changes of CP were detected by ultrasonography3 and computerised tomography.4
Every patient was given a secretin pancreozymin (SP) test and Lundh-Borgstrom (meal) test on separate days. Tests were performed as described 1 2and their order was randomised. In the SP test intravenous injection of 2 units of secretin (Boots) per kg was followed 30 minutes later by intravenous injection of 2 units of pancreozymin (Boots) per kg, duodenal juice being aspirated in 10-minute fractions for 30 minutes after each injection. The concentration of bicarbonate was measured by back titration; tryptic activity was determined by a pH-stat method using p-toluene sulphonyl arginine methyl ester as substrate.5 In the Lundh-Borgstrom test, after the patient had ingested 500 ml of the standard meal a pooled two-hour collection of duodenal juice was obtained and the tryptic activity in this sample determined.
Statistical-We used logarithmic values for bicarbonate and enzyme analyses since the skew distribution of these variables in the population may be normalised by logarithmic transformation.6-8 Secretory responses in the control and CP groups were compared by Student's t tests, while in each group differences in duodenal juice tryptic activity after stimulation by intravenous pancreozymin and the test meal were evaluated with paired t tests. Standard tests of correlation, linearity, and parallelism were then applied to the tryptic data.9
Results
SP test- Figure 1 shows the mean values and lower limits of normal for peak concentration of bicarbonate after secretin (control mean 941 mmol(mEq)/l; mean-2 SD 57-5 mmol/l), output of bicarbonate in 30 minutes after secretin (control mean 9-26 mmol; mean -2SD 5-78 mmol), and peak tryptic activity (PTA) after pancreozymin (control mean 51 6 IU/ml; mean-2 SD 26 4 IU/ml). Secretion of bicarbonate and trypsin was significantly less in the CP group than in the controls. The peak concentration of bicarbonate after secretin was reduced in 14 (see fig 4) , and the slopes of the two regression lines were not significantly different (F test: P > 005). Thus for an assigned value for PTA of, say, 25 the corresponding MTA was similar (30) when the pancreas was normal (fig 4) but only one-third of the expected result (9 6) in patients with CP. The best approximation of the ratio of trypsin response to endogenous stimulation by a test meal in the patients with CP compared with the controls proved to be 30%, with 95%/' confidence intervals of 20-50%' (fig 4) . (fig 4) . This finding was fortuitous, for the anomalous reduction in MTA compared with PTA in the CP group was detected only because MTA was closely similar to PTA in the controls. These results differ from those of Worning," in which the regression lines relating mean postprandial concentration of amylase in duodenal juice and total output of amylase secreted in response to simultaneous intra-venous infusion of secretin and pancreozymin were identical in normal people and patients with pancreatic disease. The studies were not strictly comparable, however: Worning measured amylase but not trypsin; assessed enzyme responses to a combined infusion of two different secretin and two different pancreozymin preparations rather than to pancreozymin alone; compared the output of enzyme after exogenous stimulation with the concentration of enzyme after a meal rather than using the same criterion for both tests; and included several different disease entities in the pancreatic malfunction group rather than restricting the consideration to patients with CP alone.
MTA in duodenal juice after a test meal depends not only on the amount of cholecystokinin-pancreozymin released from the intestinal mucosa but also on dilution of pancreatic enzymes by gastric, biliary, and intestinal secretions. Until these other factors have been carefully assessed the disproportionate reduction in tryptic response to endogenous compared with exogenous cholecystokinin-pancreozymin should not be taken to imply impairment of release of this hormone in CP. Whatever the explanation for this unreported phenomenon our observations validate the practical clinical usefulness of the Lundh-Borgstrom test (which is within the resources of most hospitals) when a diagnosis of CP is suspected. The SP test, which is better suited to specialist centres, provides valuable additional information about gall-bladder function and the presence of obstruction in pancreatic or biliary ducts" and ideally will still be required for a more complete appraisal in individual cases. 
